Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease—findings from the ICKD study

Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease—findings from the ICKD study

IntroductionAngiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are the antihypertensive drug class of choice in patients with chronic kidney disease (CKD). Head-to-head comparisons of the renal or non-renal outcomes between ACEI/ARB users and nonusers have not be...

Full description

Bibliographic Details
Main Authors: Narayan Prasad, Ashok Kumar Yadav, Monica Kundu, Ajay Jaryal, Dipankar Sircar, Gopesh Modi, Manisha Sahay, Natarajan Gopalakrishnan, Sanjay Vikrant, Santosh Varughese, Seema Baid-Agrawal, Shivendra Singh, Sishir Gang, Sreejith Parameswaran, Arpita Ghosh, Vivek Kumar, Vivekanand Jha
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Medicine
Subjects:
angiotensin-converting enzyme inhibitors
angiotensin receptor blockers
chronic kidney disease
cardiovascular mortality
all-cause mortality
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1060148/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1060148/full

Similar Items